微剌激促排卵方案在卵巢储备功能正常患者ivficsi中的应用

《微剌激促排卵方案在卵巢储备功能正常患者ivficsi中的应用》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、授予单位代码10089学号或申请号13275对处(E搿走5HebeiMedicalUniversity硕士学位论文在职科学学位微剌激促排卵方案在卵巢储备功能正常患者IVF/ICSI中的应用学位申请人：李宏杰导师：吴小华教授专业：妇产科学二级学院：白求恩国际和平医院2015年3月河北医科大学学位论文使用授权及知识产权归属承诺本学位论文在导师（或指导小组）的指导下，由本人独立完成。本学位论文研究所获得的研究成果，其知识产权归河北医科大学所有。河北医科大学有权对本学位论文进行交流、公幵和使用。凡发表与学位论文主要内容

2、相关的论文，第一署名为单位河北医科大学，试验材料、原始数据、申报的专利等知识产权均归河北医科大学所有。否则，承担相应法律责任。研究生签名：•lii�导师签章河北医科大学研究生学位论文独创性声明本论文是在导师指导下进行的研究工作及取得的研究成果，除了文中特别加以标注和致谢等内容外，文中不包含其他人已经发表或撰写的研究成果，指导教师对此进行了审定。本论文由本人独立撰写，文责自负。研究生签名：n导师签章：爹存―上年^•月乂日目录中文摘要·········································

3、·····································1英文摘要··············································································4英文缩写··············································································8研究论文微刺激促排卵方案在卵巢储备功能正常患者IVF/ICSI中的应用前言·················

4、·····························································9材料与方法·····································································9结果··············································································13附图·····································

5、·········································15附表··············································································19讨论··············································································22结论·················································

6、·····························26参考文献········································································26综述微刺激促排卵方案在IVF/ICSI中的应用进展·························29致谢····················································································38个人简历·····

7、·········································································39中文摘要微刺激促排卵方案在卵巢储备功能正常患者IVF/ICSI中的应用摘要据统计，不孕症在国外的发生率为15%～20%，我国的发病率为5%左右。自1978年第一例试管婴儿的诞生，IVF-ET技术不断发展，使得不孕患者在辅助生殖技术的帮助下怀孕率提高，为不孕家庭带来了福音。然而，随着辅助生殖技术的成熟发展，超促排卵方案越来越多样化，如何选择最佳的促排卵方案中获得优质

8、的卵子和胚胎，提高临床妊娠率，并同时降低并发症的发生率，获得良好的妊娠结局，是目前不孕症家庭所期待的。根据患者不孕原因及经济条件、社会因素制定出对患者最优化及最经济的治疗方案，是临床医生面临的焦点问题。微刺激促排卵方案是指在不进行垂体降调节的情况下，采用促性腺激素药物促排卵进行体外受精-胚胎移植（IVF/ICSI-ET）的一种治疗方案，因其“安全、高效、少干扰”的优点，近年来被人们逐渐